The Burgeoning “Yelpification” Of Health Care: Foundations Help Consumers Hold A Scale And A Mirror To The Health Care System
Current information about health care quality is disconnected from what consumers want. Philanthropy has a role to play in bridging the disconnect.
It will be vital for the federal government to maintain its commitment to ongoing investment in new payment and delivery models for federal health insurance programs, while sending clearer signals to other payers and health care providers.
Given that approximately 70 percent of people who die in the United States each year are Medicare beneficiaries, the new administration has an opportunity to implement changes to significantly improve the quality of end-of-life care.
New CBO AHCA Estimate: Decreases In Savings And Uninsured, Potential Market Instability For States With Major Waivers
On May 24, 2017, the CBO and Joint Committee on Taxation released their third cost estimate on H.R. 1628, the House American Health Care Act of 2017. The estimate focuses primarily on changes that occurred after the CBO scored the original bill on March 13, and the manager’s amendment on March 24.
With so many diverse reforms taking place, how is it possible to generate the evidence needed for informed decision making about payment reforms for the future?
The first Trump administration ASPE report on the ACA compares premiums in the individual market in 2013, before the ACA’s reforms and subsidies went into effect, with premiums in HealthCare.gov states. It finds that premiums more than doubled in the 39 HealthCare.gov states.
Over the next ten years, President Trump’s FY 2018 budget proposal would cut Obamacare by $1.25 trillion, reducing the deficit by $250 billion, through the AHCA. Beyond that, Trump’s budget would cut Medicaid spending by $610 billion and cut CHIP by $5.8 billion (while extending it through 2019).
Despite the drive toward value-based health care reimbursement and patients’ ever increasing financial stake in their own health care treatment, many traditional value assessment tools fail to consider value from the patient’s perspective.
On May 22, 2017, the House of Representatives and the Department of Justice jointly asked the District of Columbia Court of Appeals to continue to hold House v. Price in abeyance. This would mean continued uncertainty for insurers and the marketplaces.
Coverage arrangements in most insurance plans are designed under principles of equality rather than equity. To fully realize the benefits of medical advances, ensure access for those who could benefit most, and enhance the efficiency of our health care expenditures, we need to change this paradigm.